Citigroup advice for Gilead Sciences
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| May 24, 2019 | Citigroup | Gilead Sciences | Buy | 78.00 USD | 19.82 % |
Advice details
New York - Op 24 mei herhalen de analisten van Citigroup hun koopadvies voor het Amerikaanse biofarmaceutisch bedrijf Gilead Sciences (ISIN: US3755581036 / Mnemo: GILD). Het 12-maands koersdoel is vastgesteld op 78.0 USD
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2024 ValueSpectrum. All Rights Reserved
Developed and maintained by 